Published in Ther Adv Urol on October 01, 2011
New insights on premature ejaculation: a review of definition, classification, prevalence and treatment. Asian J Androl (2012) 0.97
Premature ejaculation: do we have effective therapy? Transl Androl Urol (2013) 0.81
Mondia whitei (Periplocaceae) prevents and Guibourtia tessmannii (Caesalpiniaceae) facilitates fictive ejaculation in spinal male rats. BMC Complement Altern Med (2013) 0.80
The role of dapoxetine hydrochloride on-demand for the treatment of men with premature ejaculation. Sci Rep (2014) 0.78
A clinical study to assess the effectiveness of a hyaluronic acid-based procedure for treatment of premature ejaculation. Int J Impot Res (2013) 0.76
Sexual dysfunction in the United States: prevalence and predictors. JAMA (1999) 14.06
Guidelines on male sexual dysfunction: erectile dysfunction and premature ejaculation. Eur Urol (2010) 3.55
Efficacy and tolerability of dapoxetine in treatment of premature ejaculation: an integrated analysis of two double-blind, randomised controlled trials. Lancet (2006) 3.23
Development and validation of a premature ejaculation diagnostic tool. Eur Urol (2007) 2.42
Tramadol HCL has promise in on-demand use to treat premature ejaculation. J Sex Med (2007) 1.96
Dapoxetine for the treatment of premature ejaculation: results from a randomized, double-blind, placebo-controlled phase 3 trial in 22 countries. Eur Urol (2009) 1.85
Changing paradigms from a historical DSM-III and DSM-IV view toward an evidence-based definition of premature ejaculation. Part II--proposals for DSM-V and ICD-11. J Sex Med (2006) 1.81
Premature ejaculation: a new approach. South Med J (1956) 1.80
Effect of SSRI antidepressants on ejaculation: a double-blind, randomized, placebo-controlled study with fluoxetine, fluvoxamine, paroxetine, and sertraline. J Clin Psychopharmacol (1998) 1.68
Efficacy of prilocaine-lidocaine cream in the treatment of premature ejaculation. J Urol (1995) 1.60
Incidence and prevalence of the sexual dysfunctions: a critical review of the empirical literature. Arch Sex Behav (1990) 1.49
Safety and efficacy of tramadol in the treatment of premature ejaculation: a double-blind, placebo-controlled, fixed-dose, randomized study. J Clin Psychopharmacol (2006) 1.33
AUA guideline on the pharmacologic management of premature ejaculation. J Urol (2004) 1.28
Sexual function of premature ejaculation patients assayed with Chinese Index of Premature Ejaculation. Asian J Androl (2004) 1.17
Efficacy and safety of dapoxetine for the treatment of premature ejaculation: integrated analysis of results from five phase 3 trials. J Sex Med (2010) 1.16
Topical eutectic mixture for premature ejaculation (TEMPE): a novel aerosol-delivery form of lidocaine-prilocaine for treating premature ejaculation. BJU Int (2006) 1.16
Premature ejaculation: clinical subgroups and etiology. J Sex Marital Ther (1989) 1.13
The Premature Ejaculation Profile: validation of self-reported outcome measures for research and practice. BJU Int (2008) 1.11
Topical anaesthetic use for treating premature ejaculation: a double-blind, randomized, placebo-controlled study. BJU Int (2004) 1.09
Disorders of orgasm and ejaculation in men. J Sex Med (2004) 1.07
Treatment of premature ejaculation in the Asia-Pacific region: results from a phase III double-blind, parallel-group study of dapoxetine. J Sex Med (2009) 1.04
Treatment benefit of dapoxetine for premature ejaculation: results from a placebo-controlled phase III trial. BJU Int (2008) 1.01
A double-blind crossover trial of clomipramine for rapid ejaculation in 15 couples. J Clin Psychiatry (1995) 1.00
Correlation between ejaculatory and erectile dysfunction. Int J Androl (2005) 0.99
Efficacy of sildenafil citrate (Viagra) in men with premature ejaculation. J Sex Med (2005) 0.98
Optimum usage of prilocaine-lidocaine cream in premature ejaculation. Andrologia (2002) 0.96
An analysis of self-reported sexual behavior in a sample of normal males. Arch Sex Behav (1984) 0.95
Efficacy and safety of fluoxetine, sertraline and clomipramine in patients with premature ejaculation: a double-blind, placebo controlled study. J Urol (1998) 0.93
Premature ejaculation: current medical treatment and new directions (CME). J Sex Med (2008) 0.93
The epidemiology of the DSM-III psychosexual dysfunctions. J Sex Marital Ther (1986) 0.92
Long-term outcome of sex therapy. Behav Res Ther (1986) 0.90
Effects of vardenafil administration on intravaginal ejaculatory latency time in men with lifelong premature ejaculation. Int J Impot Res (2009) 0.90
Terazosin in the treatment of premature ejaculation: a short-term follow-up. Int Urol Nephrol (2005) 0.90
Clomipramine in the treatment of rapid (premature) ejaculation. J Sex Marital Ther (1999) 0.89
Psycho-biological correlates of rapid ejaculation in patients attending an andrologic unit for sexual dysfunctions. Eur Urol (2004) 0.89
Improved ejaculatory latency, control and sexual satisfaction when PSD502 is applied topically in men with premature ejaculation: results of a phase III, double-blind, placebo-controlled study. J Sex Med (2010) 0.88
Predictive correlation between the International Index of Erectile Function (IIEF) and Sexual Health Inventory for Men (SHIM): implications for calculating a derived SHIM for clinical use. J Sex Med (2007) 0.87
Topical lidocaine-prilocaine spray for the treatment of premature ejaculation: a proof of concept study. Int J Impot Res (2003) 0.87
The majority of men with lifelong premature ejaculation prefer daily drug treatment: an observation study in a consecutive group of Dutch men. J Sex Med (2007) 0.86
Fluoxetine-induced sexual dysfunction. J Clin Psychiatry (1993) 0.86
Animal models of ejaculatory behavior. Curr Pharm Des (2005) 0.85
Evaluation of tramadol on demand vs. daily paroxetine as a long-term treatment of lifelong premature ejaculation. J Sex Med (2010) 0.85
Animal models of premature and retarded ejaculation. World J Urol (2005) 0.84
Delay of ejaculation induced by SB-277011, a selective dopamine D3 receptor antagonist, in the rat. J Sex Med (2008) 0.82
Effect of acute dapoxetine administration on the pudendal motoneuron reflex in anesthetized rats: comparison with paroxetine. J Urol (2007) 0.82
Can sildenafil treat primary premature ejaculation? A prospective clinical study. Int J Urol (2007) 0.80
Effect of an alpha-blocking agent (phenoxybenzamine) in the management of premature ejaculation. Acta Eur Fertil (1986) 0.80
Dapoxetine: in premature ejaculation. Drugs (2010) 0.79
The serotonin transporter plays an important role in male sexual behavior: a study in serotonin transporter knockout rats. J Sex Med (2011) 0.79
Dapoxetine for premature ejaculation. Clin Pharmacol Ther (2010) 0.78
Clomipramine versus placebo in the treatment of premature ejaculation: a pilot study. J Sex Marital Ther (1993) 0.78
Evoked sacral potentials in subjects with true premature ejaculation. Andrologia (1987) 0.78
The use of phenoxybenzamine treatment in premature ejaculation. Fertil Steril (1984) 0.78
Treatment of premature ejaculation with sertralin. Int Urol Nephrol (1998) 0.78
Safety and efficacy of escitalopram in the treatment of premature ejaculation: a double-blind, placebo-controlled, fixed-dose, randomized study. J Clin Psychopharmacol (2007) 0.78
Investigation of the neural target level of hyperthyroidism in premature ejaculation in a rat model of pharmacologically induced ejaculation. J Sex Med (2010) 0.78
Seminal plasma magnesium and premature ejaculation: a case-control study. Urol J (2005) 0.78
The medical management of premature ejaculation. J Urol (1949) 0.77
Sertraline in the treatment of premature ejaculation: a double-blind placebo controlled study. Int Urol Nephrol (1998) 0.77
Rapid ejaculation: a review of conceptual, etiological, and treatment issues. Arch Sex Behav (1995) 0.77
Fluoxetine for premature ejaculation. Am J Psychiatry (1994) 0.77
Premature ejaculation: use of ethyl aminobenzoate to prolong coitus. J Urol (1963) 0.77
9-hydroxycanthin-6-one induces penile erection and delays ejaculation. J Sex Med (2011) 0.76
Sertraline for premature ejaculation. J Clin Psychiatry (1995) 0.76
Penile vibratory threshold changes with various doses of SS-cream in patients with primary premature ejaculation. Yonsei Med J (2000) 0.76
The efficacy of duloxetine in the treatment of premature ejaculation. Int Urol Nephrol (2007) 0.76
Guidelines on male sexual dysfunction: erectile dysfunction and premature ejaculation. Eur Urol (2010) 3.55
EAU guidelines on penile curvature. Eur Urol (2012) 2.40
Long-term outcome of the use of intravesical botulinum toxin for the treatment of overactive bladder (OAB). BJU Int (2012) 2.31
Proteomic changes in renal cancer and co-ordinate demonstration of both the glycolytic and mitochondrial aspects of the Warburg effect. Proteomics (2003) 2.17
The multinational Men's Attitudes to Life Events and Sexuality (MALES) study: I. Prevalence of erectile dysfunction and related health concerns in the general population. Curr Med Res Opin (2004) 2.03
Engaging men with penile cancer in qualitative research: reflections from an interview-based study. Nurse Res (2014) 1.72
The natural progression and regression of erectile dysfunction: follow-up results from the MMAS and MALES studies. J Sex Med (2011) 1.52
Radiotherapy for node positive penile cancer: experience of the Leeds teaching hospitals. J Urol (2011) 1.48
Summary of the recommendations on sexual dysfunctions in men. J Sex Med (2010) 1.42
Operative experience of urological trainees in the UK. BJU Int (2011) 1.41
Management of ED under the "severe distress" criteria in the NHS: a real-life study. J Sex Med (2014) 1.39
A 4-year update on the safety of sildenafil citrate (Viagra). Urology (2002) 1.28
Critical analysis of the relationship between sexual dysfunctions and lower urinary tract symptoms due to benign prostatic hyperplasia. Eur Urol (2011) 1.26
Sexual experience of female partners of men with erectile dysfunction: the female experience of men's attitudes to life events and sexuality (FEMALES) study. J Sex Med (2005) 1.21
Urinary biomarker profiling in transitional cell carcinoma. Int J Cancer (2006) 1.12
An update on new oral PDE5 inhibitors for the treatment of erectile dysfunction. Nat Rev Urol (2010) 1.10
Proteomic analysis of primary cell lines identifies protein changes present in renal cell carcinoma. Proteomics (2006) 1.10
Differentiation potential of urothelium from patients with benign bladder dysfunction. BJU Int (2007) 1.09
Penile size and the 'small penis syndrome'. BJU Int (2007) 1.06
A curriculum for sexual medicine? J Sex Med (2009) 1.03
Prognostic factors in renal cell carcinoma: association of preoperative sodium concentration with survival. Clin Cancer Res (2008) 0.96
Penile cancer: organ-sparing techniques. BJU Int (2014) 0.95
Phosphodiesterase type 5 inhibitors in the management of non-neurogenic male lower urinary tract symptoms: critical analysis of current evidence. Eur Urol (2011) 0.94
Functional expression of purinergic P2 receptors and transient receptor potential channels by the human urothelium. Am J Physiol Renal Physiol (2013) 0.91
The multinational Men's Attitudes to Life Events and Sexuality (MALES) Study Phase II: understanding PDE5 inhibitor treatment seeking patterns, among men with erectile dysfunction. J Sex Med (2004) 0.91
The efficacy of tadalafil in clinical populations. J Sex Med (2005) 0.91
Surgery for locally recurrent rectal cancer. Dis Colon Rectum (2005) 0.90
Effects of testosterone on erectile function: implications for the therapy of erectile dysfunction. BJU Int (2007) 0.89
Erectile dysfunction and constructs of masculinity and quality of life in the multinational Men's Attitudes to Life Events and Sexuality (MALES) study. J Sex Med (2008) 0.85
Differences in side-effect duration and related bother levels between phosphodiesterase type 5 inhibitors. BJU Int (2009) 0.84
Pharmacotherapy for erectile dysfunction. J Sex Med (2004) 0.83
Vardenafil is effective and well-tolerated for treating erectile dysfunction in a broad population of men, irrespective of age. BJU Int (2005) 0.83
Erectile dysfunction (ED) is a shared sexual concern of couples I: couple conceptions of ED. J Sex Med (2009) 0.83
Cavernosal alpha-blockade: a new technique for investigating and treating erectile impotence by GS Brindley. J Sex Med (2008) 0.83
Improvement in erectile function on vardenafil treatment correlates with treatment satisfaction in both patients and their partners. BJU Int (2007) 0.83
Vardenafil provides reliable efficacy over time in men with erectile dysfunction. Urology (2004) 0.83
Nerve hyperplasia: a unique feature of ketamine cystitis. Acta Neuropathol Commun (2013) 0.83
Alprostadil for the treatment of impotence. Expert Opin Pharmacother (2013) 0.83
In vitro assessment of decellularized porcine dermis as a matrix for urinary tract reconstruction. BJU Int (2004) 0.82
Toll-like receptor responses of normal human urothelial cells to bacterial flagellin and lipopolysaccharide. J Urol (2011) 0.82
The impact of surgical treatment for penile cancer -- patients' perspectives. Eur J Oncol Nurs (2013) 0.81
Sexual function impairment after high energy pelvic fractures: evidence today. J Urol (2011) 0.79
The prevalence of newly diagnosed hyperlipidaemia in men with erectile dysfunction. BJU Int (2007) 0.79
A case-control study: are urological procedures risk factors for the development of infective endocarditis? BJU Int (2014) 0.78
Use of donor bladder tissues for in vitro research. BJU Int (2014) 0.77
Urothelial differentiation in vesicoureteric reflux and other urological disorders of childhood: a comparative study. Eur Urol (2005) 0.77
Patients' experiences of penile cancer. Eur Urol (2011) 0.77
Penetration and maintenance of erection with vardenafil: a time-from-dosing analysis. Can J Urol (2005) 0.76
Female Assessment of Male Erectile dysfunction detection scale (FAME): development and validation. J Sex Med (2009) 0.76
Time from dosing to sexual intercourse attempts in men taking tadalafil in clinical trials. BJU Int (2005) 0.76
Optimisation of PDE5 inhibitor therapy in men with erectile dysfunction: converting "non-responders" into "responders". Eur Urol (2006) 0.76
Response to Re: Workplace-based assessment in surgical training: experiences from the Intercollegiate Surgical Curriculum Programme. ANZ J Surg (2013) 0.75
Clinical and basic science research in sexual medicine must rely, in part, on pharmaceutical funding? J Sex Med (2010) 0.75
Comments on "Considerations for diagnostic criteria for erectile dysfunction in DSM-V". J Sex Med (2010) 0.75
Buccal mucosal grafts for urethroplasty: comparison of postoperative oral and perineal morbidity. Ann R Coll Surg Engl (2009) 0.75
Premature ejaculation: the scope of the problem. J Sex Marital Ther (2007) 0.75
Editorial comment on: daily treatment with sildenafil reverses endothelial dysfunction and oxidative stress in an animal model of insulin resistance. Eur Urol (2007) 0.75
Is premature ejaculation all in the mind? BJU Int (2005) 0.75
Masculinities, humour and care for penile cancer: a qualitative study. J Adv Nurs (2014) 0.75
Varicocele. BMJ Clin Evid (2015) 0.75
New developments in education and training in sexual medicine. J Sex Med (2013) 0.75
The evaluation of apomorphine for the treatment of erectile dysfunction. Expert Opin Drug Metab Toxicol (2012) 0.75
Who pays to publish in the journal of sexual medicine? J Sex Med (2008) 0.75
Vardenafil improves erectile function in men with erectile dysfunction irrespective of disease severity and disease classification. J Sex Med (2004) 0.75